Ventana Biotech, Inc. (VNTA)

0.0030 0.0000 (0.00%) At close: 11:05AM EDT

Ventana Biotech, Inc.

1 Bachstrasse
Butschwil 9606
Switzerland
41 44 732 60 59

Sector(s): Financial Services
Industry: Shell Companies
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Janne Christensen	Chief Exec. Officer, Pres, Chief Financial Officer, Treasurer and Director	N/A	N/A	N/A
Mr. David Holsworth	Chief Operating Officer, VP and Exec. Director	N/A	N/A	N/A
Ms. Marilyn Thom	VP of Admin. & HR	N/A	N/A	N/A
Mr. Elliott Martin	VP of Sales and Marketing	N/A	N/A	N/A
Mr. Trevor Conn	Exec. Director	N/A	N/A	N/A
Mr. Yoon Youngkeun	Sec. and Director	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. The company focuses in the areas of anti-obesity and related illnesses. The company holds rights for the formula for a medicament containing chewing gum with a composition of the extract of hoodia gordonii and 2-hydroxyoleic acid for the treatment of obesity, hypertension, and other metabolic disorders. The company develops appetite suppressant chewing gums, including the low dosage product for the over-the-counter market and the high dosage product for distribution by pharmacists. It intends to market low dosage product though drug and health food stores. The company was formerly known as Personalica, Inc. and changed its name to Ventana Biotech, Inc. in October 2008. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland.

Corporate Governance

Ventana Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.